Unraveling of Functional Activity of Primary Hippocampal Neuron-Glial Networks in Photodynamic Therapy Based on Tetracyanotetra(aryl)porphyrazines
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethics Statement
2.2. Isolation of Murine Primary Hippocampal Cultures
2.3. Photosensitizers and Irradiation Modes
2.4. Functional Calcium Imaging
2.5. Analysis of Network Characteristics of Primary Hippocampal Cultures
2.6. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
DAMPs | damage-associated molecular patterns |
DC | dendritic cell |
DIV | day of culture development in vitro |
ER | endoplasmic reticulum |
ICD | immunogenic cell death |
ROS | reactive oxygen species |
PBS | phosphate-buffered saline |
PDT | photodynamic therapy |
pz | tetracyanotetra(aryl)porphyrazines |
BBB | blood–brain barrier |
References
- Erhart, F.; Hackl, M.; Hahne, H.; Buchroithner, J.; Meng, C.; Klingenbrunner, S.; Reitermaier, R.; Fischhuber, K.; Skalicky, S.; Berger, W.; et al. Combined Proteomics/MiRNomics of Dendritic Cell Immunotherapy-Treated Glioblastoma Patients as a Screening for Survival-Associated Factors. NPJ Vaccines 2020, 5, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wen, P.Y.; Kesari, S. Malignant Gliomas in Adults. N. Engl. J. Med. 2008, 359, 492–507. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pearson, J.R.D.; Regad, T. Targeting Cellular Pathways in Glioblastoma Multiforme. Signal Transduct. Target. Ther. 2017, 2, 17040. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dougherty, T.J.; Gomer, C.J.; Henderson, B.W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic Therapy. J. Natl. Cancer Inst. 1998, 90, 889–905. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; et al. Photodynamic Therapy of Cancer: An Update. CA: A Cancer J. Clin. 2011, 61, 250–281. [Google Scholar] [CrossRef]
- Hamblin, M.R. Photodynamic Therapy for Cancer: What’s Past Is Prologue. Photochem. Photobiol. 2020, 96, 506–516. [Google Scholar] [CrossRef] [Green Version]
- Alzeibak, R.; Mishchenko, T.A.; Shilyagina, N.Y.; Balalaeva, I.V.; Vedunova, M.V.; Krysko, D.V. Targeting Immunogenic Cancer Cell Death by Photodynamic Therapy: Past, Present and Future. J. ImmunoTherapy Cancer 2021, 9, 1. [Google Scholar] [CrossRef]
- Mishchenko, T.A.; Balalaeva, I.V.; Vedunova, M.V.; Krysko, D.V. Ferroptosis and Photodynamic Therapy Synergism: Enhancing Anticancer Treatment. Trends Cancer 2021, 7, 484–487. [Google Scholar] [CrossRef]
- Lan, M.; Zhao, S.; Liu, W.; Lee, C.S.; Zhang, W.; Wang, P. Photosensitizers for Photodynamic Therapy. Adv. Healthc. Mater. 2019, 8, 1900132. [Google Scholar] [CrossRef]
- Hirschberg, H.; Berg, K.; Peng, Q. Photodynamic Therapy Mediated Immune Therapy of Brain Tumors. Neuroimmunol. Neuroinflammation 2018, 5, 1–16. [Google Scholar] [CrossRef]
- Galluzzi, L.; Vitale, I.; Warren, S.; Adjemian, S.; Agostinis, P.; Martinez, A.B.; Chan, T.A.; Coukos, G.; Demaria, S.; Deutsch, E.; et al. Consensus Guidelines for the Definition, Detection and Interpretation of Immunogenic Cell Death. J. ImmunoTherapy Cancer 2020, 8, e000337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krysko, D.V.; Garg, A.D.; Kaczmarek, A.; Krysko, O.; Agostinis, P.; Vandenabeele, P. Immunogenic Cell Death and DAMPs in Cancer Therapy. Nat. Rev. Cancer 2012, 12, 860–875. [Google Scholar] [CrossRef] [PubMed]
- Garg, A.D.; Vandenberk, L.; Koks, C.; Verschuere, T.; Boon, L.; van Gool, S.W.; Agostinis, P. Dendritic Cell Vaccines Based on Immunogenic Cell Death Elicit Danger Signals and T Cell-Driven Rejection of High-Grade Glioma. Sci. Transl. Med. 2016, 8, 328ra27. [Google Scholar] [CrossRef] [PubMed]
- Cramer, S.W.; Chen, C.C. Photodynamic Therapy for the Treatment of Glioblastoma. Front. Surg. 2020, 6, 81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stylli, S.S.; Kaye, A.H.; MacGregor, L.; Howes, M.; Rajendra, P. Photodynamic Therapy of High Grade Glioma - Long Term Survival. J. Clin. Neurosci. 2005, 12, 389–398. [Google Scholar] [CrossRef]
- Jiang, F.; Robin, A.M.; Katakowski, M.; Tong, L.; Espiritu, M.; Singh, G.; Chopp, M. Photodynamic Therapy with Photofrin in Combination with Buthionine Sulfoximine (BSO) of Human Glioma in the Nude Rat. Lasers Med. Sci. 2003, 18, 128–133. [Google Scholar] [CrossRef]
- Turubanova, V.D.; Balalaeva, I.V.; Mishchenko, T.A.; Catanzaro, E.; Alzeibak, R.; Peskova, N.N.; Efimova, I.; Bachert, C.; Mitroshina, E.V.; Krysko, O.; et al. Immunogenic Cell Death Induced by a New Photodynamic Therapy Based on Photosens and Photodithazine. J. ImmunoTherapy Cancer 2019, 7, 350. [Google Scholar] [CrossRef]
- Balalaeva, I.V.; Mishchenko, T.A.; Turubanova, V.D.; Peskova, N.N.; Shilyagina, N.Y.; Plekhanov, V.I.; Lermontova, S.A.; Klapshina, L.G.; Vedunova, M.V.; Krysko, D.V. Cyanoarylporphyrazines with High Viscosity Sensitivity: A Step towards Dosimetry-Assisted Photodynamic Cancer Treatment. Molecules 2021, 26, 5816. [Google Scholar] [CrossRef]
- Mishchenko, T.A.; Turubanova, V.D.; Mitroshina, E.V.; Alzeibak, R.; Peskova, N.N.; Lermontova, S.A.; Klapshina, L.G.; Balalaeva, I.V.; Vedunova, M.V.; Krysko, D.V. Effect of Novel Porphyrazine Photosensitizers on Normal and Tumor Brain Cells. J. Biophotonics 2020, 13, e201960077. [Google Scholar] [CrossRef]
- Savyuk, M.; Krivonosov, M.; Mishchenko, T.; Gazaryan, I.; Ivanchenko, M.; Khristichenko, A.; Poloznikov, A.; Hushpulian, D.; Nikulin, S.; Tonevitsky, E.; et al. Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an in Vitro Hypoxia Model. Antioxidants 2020, 9, 662. [Google Scholar] [CrossRef]
- Yuste, R. From the Neuron Doctrine to Neural Networks. Nat. Rev. Neurosci. 2015, 16, 487–497. [Google Scholar] [CrossRef] [PubMed]
- Mitroshina, E.V.; Krivonosov, M.I.; Burmistrov, D.E.; Savyuk, M.O.; Mishchenko, T.A.; Ivanchenko, M.V.; Vedunova, M.V. Signatures of the Consolidated Response of Astrocytes to Ischemic Factors in Vitro. Int. J. Mol. Sci. 2020, 21, 7952. [Google Scholar] [CrossRef]
- Verkhratsky, A.; Ho, M.S.; Zorec, R.; Parpura, V. (Eds.) Neuroglia in Neurodegenerative Diseases; Springer: Singapore, 2019; Volume 1175, ISBN 978-981-13-9912-1. [Google Scholar]
- Shirokova, O.M.; Frumkina, L.E.; Vedunova, M.V.; Mitroshina, E.V.; Zakharov, Y.N.; Khaspekov, L.G.; Mukhina, I.V. Morphofunctional Patterns of Neuronal Network Developing in Dissociated Hippocampal Cell Cultures. Sovrem. Tehnol. V Med. 2013, 5, 6–12. [Google Scholar]
- Mishchenko, T.A.; Mitroshina, E.V.; Usenko, A.V.; Voronova, N.V.; Astrakhanova, T.A.; Shirokova, O.M.; Kastalskiy, I.A.; Vedunova, M.V. Features of Neural Network Formation and Their Functions in Primary Hippocampal Cultures in the Context of Chronic TrkB Receptor System Influence. Front. Physiol. 2019, 9, 1925. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mitroshina, E.V.; Loginova, M.M.; Savyuk, M.O.; Krivonosov, M.I.; Mishchenko, T.A.; Tarabykin, V.S.; Ivanchenko, M.V.; Vedunova, M.V. Neuroprotective Effect of Kinase Inhibition in Ischemic Factor Modeling in Vitro. Int. J. Mol. Sci. 2021, 22, 1885. [Google Scholar] [CrossRef] [PubMed]
- Izquierdo, M.A.; Vysniauskas, A.; Lermontova, S.A.; Grigoryev, I.S.; Shilyagina, N.Y.; Balalaeva, I.V.; Klapshina, L.G.; Kuimova, M.K. Dual Use of Porphyrazines as Sensitizers and Viscosity Markers in Photodynamic Therapy. J. Mater. Chem. B 2015, 3, 1089–1096. [Google Scholar] [CrossRef]
- Lermontova, S.A.; Grigoryev, I.S.; Peskova, N.N.; Ladilina, E.Y.; Lyubova, T.S.; Plekhanov, V.I.; Grishin, I.D.; Balalaeva, I.V.; Klapshina, L.G. Cyano-Aryl Porphyrazine Pigments with Polycyclic Substituents as the Promising Agents for Photodynamic Therapy and Potential Sensors of Local Viscosity. Macroheterocycles 2019, 12, 268–275. [Google Scholar] [CrossRef]
- Vedunova, M.V.; Mishchenko, T.A.; Mitroshina, E.V.; Mukhina, I.V. TrkB-Mediated Neuroprotective and Antihypoxic Properties of Brain-Derived Neurotrophic Factor. Oxidative Med. Cell. Longev. 2015, 2015, 453901. [Google Scholar] [CrossRef]
- Kustikova, V.; Krivonosov, M.; Pimashkin, A.; Denisov, P.; Zaikin, A.; Ivanchenko, M.; Meyerov, I.; Semyanov, A. CalciumCV: Computer Vision Software for Calcium Signaling in Astrocytes. In Proceedings of the Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics); 2018; Vol. 11179 LNCS. 7th International Conference - Analysis of Images, Social networks and Texts (AIST 2018), Moscow, Russia, 5–7 July 2018. [Google Scholar]
- Loginova, M.; Mishchenko, T.; Savyuk, M.; Guseva, S.; Gavrish, M.; Krivonosov, M.; Ivanchenko, M.; Fedotova, J.; Vedunova, M. Double-Edged Sword of Vitamin D3 Effects on Primary Neuronal Cultures in Hypoxic States. Int. J. Mol. Sci. 2021, 22, 5417. [Google Scholar] [CrossRef]
- Li, X.; Lovell, J.F.; Yoon, J.; Chen, X. Clinical Development and Potential of Photothermal and Photodynamic Therapies for Cancer. Nat. Rev. Clin. Oncol. 2020, 17, 657–674. [Google Scholar] [CrossRef]
- Kostron, H.; Fiegele, T.; Akatuna, E. Combination of FOSCAN® Mediated Fluorescence Guided Resection and Photodynamic Treatment as New Therapeutic Concept for Malignant Brain Tumors. Med. Laser Appl. 2006, 21, 285–290. [Google Scholar] [CrossRef]
- Eljamel, M.S.; Goodman, C.; Moseley, H. ALA and Photofrin® Fluorescence-Guided Resection and Repetitive PDT in Glioblastoma Multiforme: A Single Centre Phase III Randomised Controlled Trial. Lasers Med. Sci. 2008, 23, 361–367. [Google Scholar] [CrossRef] [PubMed]
- Stepp, H.; Stummer, W. 5-ALA in the Management of Malignant Glioma. Lasers Surg. Med. 2018, 50, 399–419. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, G.; Wang, Q.; Liu, J.; Wu, M.; Ji, H.; Qin, Y.; Zhou, X.; Wu, L. Innovative Strategies for Enhanced Tumor Photodynamic Therapy. J. Mater. Chem. B 2021, 9, 7347–7370. [Google Scholar] [CrossRef]
- Martinez De Pinillos Bayona, A.; Mroz, P.; Thunshelle, C.; Hamblin, M.R. Design Features for Optimization of Tetrapyrrole Macrocycles as Antimicrobial and Anticancer Photosensitizers. Chem. Biol. Drug Des. 2017, 89, 192–206. [Google Scholar] [CrossRef] [Green Version]
- Diers, J.R.; Kirmaier, C.; Taniguchi, M.; Lindsey, J.S.; Bocian, D.F.; Holten, D. A Perspective on the Redox Properties of Tetrapyrrole Macrocycles. Phys. Chem. Chem. Phys. 2021, 23, 19130–19140. [Google Scholar] [CrossRef]
- Bonneau, S.; Vever-Bizet, C. Tetrapyrrole Photosensitisers, Determinants of Subcellular Localisation and Mechanisms of Photodynamic Processes in Therapeutic Approaches. Expert Opin. Ther. Pat. 2008, 18, 1011–1025. [Google Scholar] [CrossRef]
- Senge, M.O.; Fazekas, M.; Notaras, E.G.A.; Blau, W.J.; Zawadzka, M.; Locos, O.B.; Mhuircheartaigh, E.M.N. Nonlinear Optical Properties of Porphyrins. Adv. Mater. 2007, 19, 2737–2774. [Google Scholar] [CrossRef]
- Taniguchi, M.; Du, H.; Lindsey, J.S. Virtual Libraries of Tetrapyrrole Macrocycles. Combinatorics, Isomers, Product Distributions, and Data Mining. J. Chem. Inf. Modeling 2011, 51, 2233–2247. [Google Scholar] [CrossRef]
- Kuimova, M.K. Mapping Viscosity in Cells Using Molecular Rotors. Phys. Chem. Chem. Phys. 2012, 14, 12671–12686. [Google Scholar] [CrossRef]
- Kuimova, M.K.; Botchway, S.W.; Parker, A.W.; Balaz, M.; Collins, H.A.; Anderson, H.L.; Suhling, K.; Ogilby, P.R. Imaging Intracellular Viscosity of a Single Cell during Photoinduced Cell Death. Nat. Chem. 2009, 1, 69–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vyšniauskas, A.; Qurashi, M.; Kuimova, M.K. A Molecular Rotor That Measures Dynamic Changes of Lipid Bilayer Viscosity Caused by Oxidative Stress. Chem. Eur. J. 2016, 22, 13210–13217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lermontova, S.A.; Grigor’ev, I.S.; Ladilina, E.Y.; Balalaeva, I.V.; Shilyagina, N.Y.; Klapshina, L.G. Porphyrazine Structures with Electron-Withdrawing Substituents as the Base for Materials for Photonics and Biomedicine. Russ. J. Coord. Chem./Koord. Khimiya 2018, 44, 301–315. [Google Scholar] [CrossRef]
- Lermontova, S.A.; Grigoryev, I.S.; Shilyagina, N.Y.; Peskova, N.N.; Balalaeva, I.V.; Shirmanova, M.V.; Klapshina, L.G. New Porphyrazine Macrocycles with High Viscosity-Sensitive Fluorescence Parameters. Russ. J. Gen. Chem. 2016, 86, 1330–1338. [Google Scholar] [CrossRef]
- Turubanova, V.D.; Mishchenko, T.A.; Balalaeva, I.V.; Efimova, I.; Peskova, N.N.; Klapshina, L.G.; Lermontova, S.A.; Bachert, C.; Krysko, O.; Vedunova, M.V.; et al. Novel Porphyrazine-Based Photodynamic Anti-Cancer Therapy Induces Immunogenic Cell Death. Sci. Rep. 2021, 11, 7205. [Google Scholar] [CrossRef]
- Lakpa, K.L.; Khan, N.; Afghah, Z.; Chen, X.; Geiger, J.D. Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance. J. Neuroimmune Pharmacol. 2021, 16, 219–237. [Google Scholar] [CrossRef]
- Sampson, J.H.; Gunn, M.D.; Fecci, P.E.; Ashley, D.M. Brain Immunology and Immunotherapy in Brain Tumours. Nat. Rev. Cancer 2020, 20, 12–25. [Google Scholar] [CrossRef]
- Garg, A.D.; Coulie, P.G.; van den Eynde, B.J.; Agostinis, P. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape. Trends Immunol. 2017, 38, 577–593. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Savyuk, M.O.; Turubanova, V.D.; Mishchenko, T.A.; Lermontova, S.A.; Klapshina, L.G.; Krysko, D.V.; Vedunova, M.V. Unraveling of Functional Activity of Primary Hippocampal Neuron-Glial Networks in Photodynamic Therapy Based on Tetracyanotetra(aryl)porphyrazines. Cells 2022, 11, 1212. https://doi.org/10.3390/cells11071212
Savyuk MO, Turubanova VD, Mishchenko TA, Lermontova SA, Klapshina LG, Krysko DV, Vedunova MV. Unraveling of Functional Activity of Primary Hippocampal Neuron-Glial Networks in Photodynamic Therapy Based on Tetracyanotetra(aryl)porphyrazines. Cells. 2022; 11(7):1212. https://doi.org/10.3390/cells11071212
Chicago/Turabian StyleSavyuk, Maria O., Victoria D. Turubanova, Tatiana A. Mishchenko, Svetlana A. Lermontova, Larisa G. Klapshina, Dmitri V. Krysko, and Maria V. Vedunova. 2022. "Unraveling of Functional Activity of Primary Hippocampal Neuron-Glial Networks in Photodynamic Therapy Based on Tetracyanotetra(aryl)porphyrazines" Cells 11, no. 7: 1212. https://doi.org/10.3390/cells11071212
APA StyleSavyuk, M. O., Turubanova, V. D., Mishchenko, T. A., Lermontova, S. A., Klapshina, L. G., Krysko, D. V., & Vedunova, M. V. (2022). Unraveling of Functional Activity of Primary Hippocampal Neuron-Glial Networks in Photodynamic Therapy Based on Tetracyanotetra(aryl)porphyrazines. Cells, 11(7), 1212. https://doi.org/10.3390/cells11071212